Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Integrin alpha 5 beta 1

Integrin alpha 5 beta 1

Brief Information

Name:Integrin alpha-5/beta-1
Target Synonym:Integrin alpha5beta1
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

IT1-H82Wa-SPR
 Integrin alpha 5 beta 1 SPR

Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) captured on Biotin CAP-Series S Sensor Chip can bind Human Fibronectin with an affinity constant of 4.4 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

IT1-H82Wa-ELISA
 Integrin alpha 5 beta 1 ELISA

Immobilized Recombinant Human Fibronectin at 2 μg/mL (100 μL/well) can bind Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) with a linear range of 1-16 ng/mL (QC tested).

Synonym Name

Integrin alpha 5 beta 1,ITGA5&ITGB1

Background

Integrin alpha 5 beta 1 / Integrin α5β1, which is a major cellular receptor for the extracellular matrix protein fibronectin and plays a fundamental role during mammalian development., is composed of α5 (ITGA5/CD49e) and β1 (ITGB1/CD29) subunits. Integrins are adhesion receptors that transmit bidirectional signals across the plasma membrane. The Integrin alpha 5 beta 1 and its primary extracellular matrix ligand fibronectin (Fn) are of great biological importance.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Recombinant human endostatin (Simcere) YH-16 Approved Jiangsu Simcere Pharmaceutical Co Ltd Endostar, 恩度, Endu Mainland China Carcinoma, Non-Small-Cell Lung Shandong Simcere Bio-Pharmaceutical Co Ltd 2005-09-12 Head and Neck Neoplasms; Esophageal Neoplasms; Ascites; Osteosarcoma; Nasopharyngeal Carcinoma; Pleural Effusion, Malignant; Brain metastases; Carcinoma, Non-Small-Cell Lung Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
PF-4605412 PF-04605412 Pfizer Pharmaceuticals Ltd (China) Details
Pegylated recombinant human endostatin (Tsinghua University) M-2ES; CRB-0401 Phase 1 Clinical Tsinghua University, Beijing Protgen Biotechnology Development Co Ltd, Beijing Proji Pharmaceutical Technology Co Ltd Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung Details
VAX-014 VAX-014 Phase 1 Clinical Vaxiion Therapeutics Llc Solid tumours Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message